Lindus Health Named a 2025 Fierce CRO Award Finalist in the Outstanding Patient Recruitment and Retention Category

We are thrilled to announce that Lindus Health has been named a finalist for the prestigious Fierce CRO Award in the category of Outstanding Patient Recruitment and Retention, recognizing our innovative approach to solving one of clinical research's most persistent challenges.

Lindus Health has distinguished itself through its pioneering Patient Identification Center (PIC) technique, which utilizes AI-powered algorithms to identify eligible patients from a database of over 30 million electronic health records. What sets our approach apart is not just the technology, but our deep understanding of how healthcare data is actually recorded and coded by practitioners. Our in-house experts create highly customized searches based on both standard criteria and nuanced knowledge of medical record terminology, significantly improving patient identification accuracy.

The results speak for themselves. In the FLORA trial with Myota, we enrolled prediabetic individuals within strict metabolic parameters in just four months—less than half the projected timeline—while achieving a remarkable 54% screening conversion rate, far exceeding the industry benchmark of approximately 10%. Similarly impressive results have been demonstrated across studies in postpartum depression, severe insomnia, and other therapeutic areas.

The Fierce CRO Awards celebrate exceptional achievements and innovations by Contract Research Organizations (CROs). These awards honor CROs who display excellence, performance, innovation, and leadership in delivering high-quality research and development services. By recognizing the excellence of CROs, the awards aim to highlight the critical role they play in advancing life sciences research and improving patient outcomes. This recognition underscores our commitment to redefining what modern clinical research should look like, setting a new standard for patient recruitment and retention in the industry.

Click here to view the full list of finalists by category.

Continue reading

More from Lindus

Jan 8, 2026

Dr. Paul Billings Joins Lindus Health's Scientific Advisory Board

Lindus Health has announced the appointment of Dr. Paul Billings to its Scientific Advisory Board, strengthening its expertise in diagnostic and genomic medicine. A recognized leader in diagnostics with decades of experience across industry and clinical research, Dr. Billings will help guide Lindus Health’s strategy for designing and executing high-quality diagnostic clinical trials, supporting faster, more reliable paths from diagnostic innovation to patient impact.

Dec 11, 2025

Lindus Health and Quotient Sciences Partner to Accelerate Drug Development from First-in-Human to Pivotal Trials

This collaboration is essential to eliminating traditional barriers in patient recruitment and reducing friction when transitioning between development stages and CRO partners, ultimately accelerating the delivery of breakthrough treatments to patients.

Nov 13, 2025

Lindus Health Named Rising Star in the 2025 Deloitte Technology Fast 50

This prestigious recognition reflects Lindus’ ongoing commitment to developing adaptive, innovative technology that fixes the broken Contract Research Organization (CRO) model through its all-in-one solution.

Oct 23, 2025

All-in-One CRO Solution Lindus Health Welcomes Heather Davis as Vice President of US Clinical Operations

Heather Davis joins the executive team, bringing 30 years of experience to continue expanding Lindus Health's footprint in North America.